Literature DB >> 10781099

A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

R Vidal1, T Revesz, A Rostagno, E Kim, J L Holton, T Bek, M Bojsen-Møller, H Braendgaard, G Plant, J Ghiso, B Frangione.   

Abstract

Familial Danish dementia (FDD), also known as heredopathia ophthalmo-oto-encephalica, is an autosomal dominant disorder characterized by cataracts, deafness, progressive ataxia, and dementia. Neuropathological findings include severe widespread cerebral amyloid angiopathy, hippocampal plaques, and neurofibrillary tangles, similar to Alzheimer's disease. N-terminal sequence analysis of isolated leptomeningeal amyloid fibrils revealed homology to ABri, the peptide originated by a point mutation at the stop codon of gene BRI in familial British dementia. Molecular genetic analysis of the BRI gene in the Danish kindred showed a different defect, namely the presence of a 10-nt duplication (795-796insTTTAATTTGT) between codons 265 and 266, one codon before the normal stop codon 267. The decamer duplication mutation produces a frame-shift in the BRI sequence generating a larger-than-normal precursor protein, of which the amyloid subunit (designated ADan) comprises the last 34 C-terminal amino acids. This de novo-created amyloidogenic peptide, associated with a genetic defect in the Danish kindred, stresses the importance of amyloid formation as a causative factor in neurodegeneration and dementia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781099      PMCID: PMC18333          DOI: 10.1073/pnas.080076097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Luria testing in demented patients.

Authors:  B Ernst; M A Dalby; A Dalby
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

Review 2.  Exploring the etiology of Alzheimer disease using molecular genetics.

Authors:  C L Lendon; F Ashall; A M Goate
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

3.  Transthyretin amyloidosis: a new mutation associated with dementia.

Authors:  R B Petersen; H Goren; M Cohen; S L Richardson; N Tresser; A Lynn; M Gali; M Estes; P Gambetti
Journal:  Ann Neurol       Date:  1997-03       Impact factor: 10.422

4.  Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type.

Authors:  J Ghiso; M Haltia; F Prelli; J Novello; B Frangione
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

5.  A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.

Authors:  R Crook; A Verkkoniemi; J Perez-Tur; N Mehta; M Baker; H Houlden; M Farrer; M Hutton; S Lincoln; J Hardy; K Gwinn; M Somer; A Paetau; H Kalimo; R Ylikoski; M Pöyhönen; S Kucera; M Haltia
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

6.  Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia.

Authors:  S H Kim; R Wang; D J Gordon; J Bass; D F Steiner; D G Lynn; G Thinakaran; S C Meredith; S S Sisodia
Journal:  Nat Neurosci       Date:  1999-11       Impact factor: 24.884

7.  Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins.

Authors:  W Deleersnijder; G Hong; R Cortvrindt; C Poirier; P Tylzanowski; K Pittois; E Van Marck; J Merregaert
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

Review 8.  Genetic abnormalities and pathogenesis of familial amyloidotic polyneuropathy.

Authors:  T Murakami; M Uchino; M Ando
Journal:  Pathol Int       Date:  1995-01       Impact factor: 2.534

9.  Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

Authors:  R Vidal; F Garzuly; H Budka; M Lalowski; R P Linke; F Brittig; B Frangione; T Wisniewski
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

10.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.

Authors:  B Ghetti; P Piccardo; M G Spillantini; Y Ichimiya; M Porro; F Perini; T Kitamoto; J Tateishi; C Seiler; B Frangione; O Bugiani; G Giaccone; F Prelli; M Goedert; S R Dlouhy; F Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

View more
  99 in total

Review 1.  Genetic animal models of cerebral vasculopathies.

Authors:  Jeong Hyun Lee; Brian J Bacskai; Cenk Ayata
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Specific chaperones and regulatory domains in control of amyloid formation.

Authors:  Michael Landreh; Anna Rising; Jenny Presto; Hans Jörnvall; Jan Johansson
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

3.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

4.  PYROGLUTAMATE FORMATION AT THE N-TERMINI OF ABRI MOLECULES IN FAMILIAL BRITISH DEMENTIA IS NOT RESTRICTED TO THE CENTRAL NERVOUS SYSTEM.

Authors:  Yasushi Tomidokoro; Akira Tamaoka; Janice L Holton; Tammaryn Lashley; Blas Frangione; Tamas Revesz; Agueda Rostagno; Jorge Ghiso
Journal:  Hirosaki Igaku       Date:  2010-07-08

5.  Glycosylation of BRI2 on asparagine 170 is involved in its trafficking to the cell surface but not in its processing by furin or ADAM10.

Authors:  Maria Tsachaki; Despina Serlidaki; Andriana Fetani; Vasiliki Zarkou; Ismini Rozani; Jorge Ghiso; Spiros Efthimiopoulos
Journal:  Glycobiology       Date:  2011-07-13       Impact factor: 4.313

6.  Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits.

Authors:  Robert Tamayev; Shuji Matsuda; Mauro Fà; Ottavio Arancio; Luciano D'Adamio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 7.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

8.  Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides.

Authors:  Gorazd B Stokin; Angels Almenar-Queralt; Shermali Gunawardena; Elizabeth M Rodrigues; Tomás Falzone; Jungsu Kim; Concepción Lillo; Stephanie L Mount; Elizabeth A Roberts; Eileen McGowan; David S Williams; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2008-08-11       Impact factor: 6.150

9.  BRI2 (ITM2b) inhibits Abeta deposition in vivo.

Authors:  Jungsu Kim; Victor M Miller; Yona Levites; Karen Jansen West; Craig W Zwizinski; Brenda D Moore; Fredrick J Troendle; Maralyssa Bann; Christophe Verbeeck; Robert W Price; Lisa Smithson; Leilani Sonoda; Kayleigh Wagg; Vijayaraghavan Rangachari; Fanggeng Zou; Steven G Younkin; Neill Graff-Radford; Dennis Dickson; Terrone Rosenberry; Todd E Golde
Journal:  J Neurosci       Date:  2008-06-04       Impact factor: 6.167

Review 10.  Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Authors:  Thomas Wisniewski; Allal Boutajangout
Journal:  Brain Struct Funct       Date:  2009-12-10       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.